# | FIGO Stage | Histology | Grade | FSS | Adjuvant Chemo | Recurrence | Time to Recur. (months) | Site of Recurrence | Treatment at Recur. | Follow-Up after Recur. (months) | Status | Time from Treatment to Death (months) | Cause of Death |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | IA | Mucinous | – | Yes | No | Yes | 18 | Bone & CNS | Radiation + chemo | 6 | DOD | 36 | DOD |
2 | IA | LGS | – | Yes | No | Yes | 43 | Ovary | Surgery | 14 | NED | – | |
3 | IC1 | Mixed | 1 | No | No | Yes | 24 | Pelvic cavity | Surgery + chemo | 2.5 | NED | – | |
4 | IC2 | HGS | – | No | Yes | Yes | 27 | Paraaortic LN & pelvic cavity | Surgery + chemo | 3 | NED | – | |
5 | IC1 | CCC | – | No | Yes | Yes | 16 | Pelvic cavity | Surgery + chemo | 6 | AWD | – | |
6 | IC1 | CCC | – | No | Yes | Yes | 10 | Pelvic LN & pelvic cavity | Chemo | 11 | DOD | 28 | DOD |
7 | IA | HGS | – | No | Yes | Yes | 26 | Vaginal cuff | Surgery + chemo | 10 | NED | – | |
8 | IC2 | CCC | – | No | Yes | Yes | 4.5 | Peritoneal & liver | Chemo | 19 | DOD | 30 | DOD |
9 | IC1 | Mucinous | – | No | Yes | No | – | – | – | – | DEAD | 72 | Lung cancer |
10 | IA | Mucinous | – | No | No | No | – | – | – | – | DEAD | 18 | Jejunal cancer |
11 | IC | Mucinous | – | No | No | No | – | – | – | – | DEAD | 30 | Unknown |
Total, mean (range) | IA (36%)IC (64%) | 21 (4.5–43) | 9 (2.5–19) | 36 (28–72) |